Dr. Matthew Herrmann, MD
Internal Medicine (Internal Medicine Physician)
150 N Robertson Blvd Ste 300
Beverly Hills, CA 90211
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 11
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 113
Licensed in California since 2017, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
CA license A150607 (first issued 2017; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
Medical groups
- Aids Healthcare Foundation (101 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 113
- Services billed
- 719
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Insertion of needle into vein for collection of blood sample | 202 | 98 |
| Established patient office or other outpatient visit, 20-29 minutes | 186 | 93 |
| Established patient office or other outpatient visit, 30-39 minutes | 55 | 38 |
| Admn sarscov2 vacc 1 dose | 24 | 24 |
| Administration of influenza virus vaccine | 23 | 23 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 15 | 15 |
| Adm sarscv2 bvl 50mcg/.5ml a | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Beverly Hills, CA | 558 |
| Biktarvy (bictegrav/emtricit/tenofov ala) | 489 |
| Dovato (dolutegravir sodium/lamivudine) | 277 |
| Amlodipine Besylate Other prescribers in Beverly Hills, CA | 267 |
| Olmesartan Medoxomil Other prescribers in Beverly Hills, CA | 247 |
| Gabapentin Other prescribers in Beverly Hills, CA | 247 |
| Metformin Hcl Other prescribers in Beverly Hills, CA | 204 |
| Tamsulosin Hcl Other prescribers in Beverly Hills, CA | 201 |
| Tivicay (dolutegravir sodium) | 172 |
| Testosterone Other prescribers in Beverly Hills, CA | 169 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 188 payments worth $136,438 in total to this clinician.
| Viiv Healthcare Company | $129,283 |
|---|---|
| Gilead Sciences, Inc. | $6,800 |
| EMD Serono, Inc. | $230 |
| Exact Sciences Corporation | $42.08 |
| Tolmar, Inc. | $23.75 |
| Pfizer Inc. | $20.63 |
| AbbVie Inc. | $20.40 |
| Merck Sharp & Dohme LLC | $18.48 |
| Compensation for services other than consulting (speaking, faculty) | $77,675 |
|---|---|
| Consulting Fee | $27,826 |
| Travel and Lodging | $25,134 |
| Food and Beverage | $5,627 |
| Gift | $176 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Viiv Healthcare Company Aug 6, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $9,750 |
| Viiv Healthcare Company Jun 25, 2025 | Consulting Fee CABENUVA · HIV | $9,588 |
| Viiv Healthcare Company Oct 15, 2025 | Travel and Lodging CABENUVA · HIV · travel to Honolulu, HI · in-kind | $8,031 |
| Viiv Healthcare Company Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $7,150 |
| Viiv Healthcare Company Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $7,150 |
| Viiv Healthcare Company Dec 2, 2025 | Consulting Fee | $6,529 |
| Gilead Sciences, Inc. Dec 12, 2025 | Consulting Fee Yeztugo · HIV Company’s description;4289841;VEM US;12779645 | $4,560 |
| Viiv Healthcare Company Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $3,900 |
| Viiv Healthcare Company Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $3,900 |
| Viiv Healthcare Company Jan 28, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $3,900 |
All 66 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Gilead Sciences, Inc. Dec 18, 2025 | Travel and Lodging Yeztugo · HIV · travel to Fort Worth, TX Company’s description;4289731;VEM US;12779645 | $99.91 |
| Gilead Sciences, Inc. Dec 18, 2025 | Travel and Lodging Yeztugo · HIV · travel to Fort Worth, TX Company’s description;4289802;VEM US;12779645 | $84.85 |
| Gilead Sciences, Inc. Dec 18, 2025 | Travel and Lodging Yeztugo · HIV · travel to Fort Worth, TX Company’s description;4289889;VEM US;12779645 | $35.34 |
| Gilead Sciences, Inc. Dec 18, 2025 | Travel and Lodging Yeztugo · HIV · travel to Fort Worth, TX Company’s description;4289643;VEM US;12779645 | $30.57 |
| Viiv Healthcare Company Dec 15, 2025 | Travel and Lodging CABENUVA · HIV · travel to Sherman Oaks, CA | $267 |
| Gilead Sciences, Inc. Dec 12, 2025 | Consulting Fee Yeztugo · HIV Company’s description;4289841;VEM US;12779645 | $4,560 |
| Viiv Healthcare Company Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $2,600 |
| Gilead Sciences, Inc. Dec 4, 2025 | Travel and Lodging Yeztugo · HIV · travel to Fort Worth, TX · in-kind Company’s description;4289686;VEM US;12779645 | $951 |
| Gilead Sciences, Inc. Dec 4, 2025 | Travel and Lodging Yeztugo · HIV · travel to Fort Worth, TX · in-kind Company’s description;4289885;VEM US;12779645 | $234 |
| Gilead Sciences, Inc. Dec 4, 2025 | Travel and Lodging Yeztugo · HIV · travel to Fort Worth, TX · in-kind Company’s description;4289763;VEM US;12779645 | $156 |
| Viiv Healthcare Company Dec 2, 2025 | Consulting Fee | $6,529 |
| Viiv Healthcare Company Dec 2, 2025 | Travel and Lodging travel to Hayes, Great Britain (UK) | $2,609 |
| Viiv Healthcare Company Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $7,150 |
| Viiv Healthcare Company Nov 26, 2025 | Travel and Lodging CABENUVA · HIV · travel to Honolulu, HI | $47.76 |
| Viiv Healthcare Company Nov 26, 2025 | Travel and Lodging CABENUVA · HIV · travel to Honolulu, HI | $25.85 |
| Viiv Healthcare Company Nov 25, 2025 | Gift CABENUVA; APRETUDE · HIV · in-kind Company’s descriptionDisposable items provided to support appropriate and safe administration of ViiV injectable therapies for certain patients based on clinical need. | $176 |
| Viiv Healthcare Company Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $1,950 |
| Viiv Healthcare Company Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $3,900 |
| Viiv Healthcare Company Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $2,600 |
| Viiv Healthcare Company Oct 15, 2025 | Travel and Lodging CABENUVA · HIV · travel to Honolulu, HI · in-kind | $8,031 |
| Viiv Healthcare Company Oct 15, 2025 | Travel and Lodging CABENUVA · HIV · travel to Honolulu, HI · in-kind | $746 |
| Viiv Healthcare Company Oct 7, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $238 |
| Viiv Healthcare Company Sep 10, 2025 | Travel and Lodging APRETUDE · HIV · travel to Sherman Oaks, CA | $366 |
| Viiv Healthcare Company Sep 8, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $308 |
| Viiv Healthcare Company Sep 8, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $31.41 |
| Viiv Healthcare Company Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $2,600 |
| Viiv Healthcare Company Aug 6, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $9,750 |
| Viiv Healthcare Company Aug 4, 2025 | Consulting Fee | $3,900 |
| Viiv Healthcare Company Jul 14, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $2,600 |
| Viiv Healthcare Company Jul 7, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $2,600 |
| Viiv Healthcare Company Jun 26, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $597 |
| Viiv Healthcare Company Jun 25, 2025 | Consulting Fee CABENUVA · HIV | $9,588 |
| Viiv Healthcare Company Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $2,600 |
| Viiv Healthcare Company May 8, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $1,838 |
| Viiv Healthcare Company May 8, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $344 |
| Viiv Healthcare Company May 8, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $31.41 |
| Viiv Healthcare Company May 8, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $31.41 |
| Viiv Healthcare Company Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $1,300 |
| Viiv Healthcare Company Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $975 |
| Viiv Healthcare Company Apr 11, 2025 | Travel and Lodging CABENUVA · HIV · travel to Sherman Oaks, CA | $253 |
| Viiv Healthcare Company Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $7,150 |
| Viiv Healthcare Company Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $3,900 |
| Viiv Healthcare Company Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $1,300 |
| Viiv Healthcare Company Mar 28, 2025 | Travel and Lodging CABENUVA · HIV · travel to Hilo, HI | $566 |
| Viiv Healthcare Company Mar 28, 2025 | Travel and Lodging CABENUVA · HIV · travel to Honolulu, HI | $287 |
| Viiv Healthcare Company Mar 28, 2025 | Travel and Lodging APRETUDE · HIV · travel to Palo Alto, CA | $63.92 |
| Viiv Healthcare Company Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $1,300 |
| Viiv Healthcare Company Mar 20, 2025 | Consulting Fee CABENUVA · HIV | $3,250 |
| Viiv Healthcare Company Feb 28, 2025 | Travel and Lodging travel to Hollywood, FL · in-kind | $440 |
| Viiv Healthcare Company Feb 27, 2025 | Travel and Lodging APRETUDE · HIV · travel to Palo Alto, CA · in-kind | $1,528 |
| Viiv Healthcare Company Feb 27, 2025 | Travel and Lodging APRETUDE · HIV · travel to Palo Alto, CA · in-kind | $336 |
| Viiv Healthcare Company Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $2,600 |
| Viiv Healthcare Company Jan 30, 2025 | Travel and Lodging APRETUDE · HIV · travel to Riverside, CA · in-kind | $922 |
| Viiv Healthcare Company Jan 28, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $3,900 |
| Viiv Healthcare Company Jan 28, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $3,900 |
| Viiv Healthcare Company Jan 28, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $1,950 |
| Viiv Healthcare Company Jan 28, 2025 | Compensation for services other than consulting (speaking, faculty) CABENUVA · HIV | $1,950 |
| Viiv Healthcare Company Jan 17, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $3,900 |
| Viiv Healthcare Company Jan 17, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $1,300 |
| Viiv Healthcare Company Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) APRETUDE · HIV | $3,900 |
| Viiv Healthcare Company Jan 16, 2025 | Travel and Lodging travel to Hollywood, FL · in-kind | $3,068 |
| Viiv Healthcare Company Jan 16, 2025 | Travel and Lodging travel to Hollywood, FL · in-kind | $444 |
| Viiv Healthcare Company Jan 16, 2025 | Travel and Lodging travel to Hollywood, FL · in-kind | $31.02 |
| Viiv Healthcare Company Jan 16, 2025 | Travel and Lodging travel to Hollywood, FL · in-kind | $31.02 |
| Viiv Healthcare Company Jan 16, 2025 | Travel and Lodging travel to Hollywood, FL · in-kind | $31.02 |
| Viiv Healthcare Company Jan 16, 2025 | Travel and Lodging travel to Hollywood, FL · in-kind | $31.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,200 in research payments for these studies, mostly to the institutions running them.
- Prefer-la patient reported exp and benefit of treatment w cabenuva
Viiv Healthcare Company
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.